Sarah Derby

749 total citations
9 papers, 45 citations indexed

About

Sarah Derby is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sarah Derby has authored 9 papers receiving a total of 45 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Sarah Derby's work include PARP inhibition in cancer therapy (4 papers), Glioma Diagnosis and Treatment (3 papers) and DNA Repair Mechanisms (2 papers). Sarah Derby is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Glioma Diagnosis and Treatment (3 papers) and DNA Repair Mechanisms (2 papers). Sarah Derby collaborates with scholars based in United Kingdom and Switzerland. Sarah Derby's co-authors include Anthony J. Chalmers, Ross Carruthers, Ariel Yuhan Ong, Mary Joan MacLeod, Rosalind Adam, David J. McLernon, Peter Murchie, Melanie Turner, Helen Bulbeck and Allan James and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Sarah Derby

8 papers receiving 45 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Derby United Kingdom 4 19 17 16 12 7 9 45
Tienan Yi China 5 19 1.0× 15 0.9× 22 1.4× 12 1.0× 6 0.9× 14 55
Diana Bello Roufai France 4 35 1.8× 20 1.2× 8 0.5× 9 0.8× 5 0.7× 9 53
Heather Hannah Canada 3 16 0.8× 21 1.2× 10 0.6× 12 1.0× 11 1.6× 6 55
Magdalena Stankiewicz Poland 4 15 0.8× 17 1.0× 6 0.4× 10 0.8× 12 1.7× 18 60
Vladimir Ivanov Russia 6 14 0.7× 9 0.5× 17 1.1× 6 0.5× 3 0.4× 16 82
Claire Smith United Kingdom 5 10 0.5× 28 1.6× 12 0.8× 9 0.8× 10 1.4× 5 63
Ting Ying Ng China 5 37 1.9× 9 0.5× 11 0.7× 5 0.4× 3 0.4× 5 55
Tripti Kumar United States 3 17 0.9× 10 0.6× 17 1.1× 7 0.6× 9 1.3× 9 50
Á. Montesa Pino Spain 5 14 0.7× 26 1.5× 11 0.7× 6 0.5× 13 1.9× 12 48
Ewa Szutowicz-Zielińska Poland 3 23 1.2× 17 1.0× 9 0.6× 8 0.7× 4 0.6× 5 39

Countries citing papers authored by Sarah Derby

Since Specialization
Citations

This map shows the geographic impact of Sarah Derby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Derby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Derby more than expected).

Fields of papers citing papers by Sarah Derby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Derby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Derby. The network helps show where Sarah Derby may publish in the future.

Co-authorship network of co-authors of Sarah Derby

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Derby. A scholar is included among the top collaborators of Sarah Derby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Derby. Sarah Derby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Derby, Sarah, Mark R. Jackson, Karin Williams, et al.. (2024). Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1371–1378. 13 indexed citations
2.
Derby, Sarah, Jon Stobo, Allan James, et al.. (2023). OS09.3.A FINAL RESULTS OF THE MGMT UNMETHYLATED ARM OF PARADIGM-2: A PHASE I STUDY OF OLAPARIB AND RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM). Neuro-Oncology. 25(Supplement_2). ii20–ii21. 1 indexed citations
3.
Derby, Sarah, Anthony J. Chalmers, & Ross Carruthers. (2021). Radiotherapy-Poly(ADP-ribose) Polymerase Inhibitor Combinations: Progress to Date. Seminars in Radiation Oncology. 32(1). 15–28. 11 indexed citations
4.
Turner, Melanie, Peter Murchie, Sarah Derby, et al.. (2021). Is stroke incidence increased in survivors of adult cancers? A systematic review and meta-analysis. Journal of Cancer Survivorship. 16(6). 1414–1448. 12 indexed citations
5.
Derby, Sarah, Matthew Forshaw, Derek Grose, et al.. (2021). Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus. BMJ Open Gastroenterology. 8(1). e000492–e000492. 4 indexed citations
6.
Derby, Sarah, Liam Welsh, Thomas Hundsberger, et al.. (2021). The potential utility of end-binding protein 1 (EB1) as response-predictive biomarker for lisavanbulin: A phase 2 study of lisavanbulin (BAL101553) in adult patients with recurrent glioblastoma.. Journal of Clinical Oncology. 39(15_suppl). TPS2068–TPS2068. 2 indexed citations
7.
Chalmers, Anthony J., Rodrigo Gutierrez‐Quintana, Karin Williams, et al.. (2021). Abstract IA-006: Enhancing the therapeutic ratio for glioblastoma by combining radiation therapy with PARP inhibitors. Clinical Cancer Research. 27(8_Supplement). IA–6. 1 indexed citations
8.
Derby, Sarah, et al.. (2019). Systemic anti cancer treatment for penile cancer: Real world experience of tertiary cancer centre. European Urology Supplements. 18(11). e3617–e3617. 1 indexed citations
9.
Derby, Sarah, Janet Graham, & David E. McIntosh. (2019). An unusual cause of paraesthesia in a neo-adjuvant gastro-oesophageal cancer. BMJ Case Reports. 12(8). e225450–e225450.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026